Inventor · disambiguated record
Lynne Georgopoulos
Also filed as: GEORGOPOULOS LYNNE · GEORGOPOULOS LYNNE M
5 granted patents·5 pending applications·9 citations·filing 2012–2024
73Inventor score
Top patents by PatentIndex Score
10 records- 0186US9919032B2Method for administering a sustained release formulationPHASEBIO PHARMACEUTICALS INC·Filed 2016·Granted Mar 20, 2018·3 cites·20 claims
- 0279US10688156B2Methods and compositions for treating muscle disease and disordersPHASEBIO PHARMACEUTICALS INC·Filed 2016·Granted Jun 23, 2020·2 cites·15 claims
- 0377US2025332221A1Methods and compositions for treating muscle disease and disordersIMMUNOFORGE CO LTD·Filed 2024·Application pending·0 cites
- 0473US2022288170A1Methods and compositions for treating muscle disease and disordersPHASEBIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0572US9561262B2Use of modified vasoactive intestinal peptides in the treatment of hypertensionGEORGOPOULOS LYNNE M·Filed 2012·Granted Feb 7, 2017·4 cites·22 claims
- 0669US11266719B2Methods and compositions for treating muscle disease and disordersPHASEBIO PHARMACEUTICALS INC·Filed 2020·Granted Mar 8, 2022·0 cites·15 claims
- 0758US2015290328A1Formulations of active agents for sustained releasePHASEBIO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0853US10940182B2Use of modified vasoactive intestinal peptides in the treatment of hypertensionPHASEBIO PHARMACEUTICALS INC·Filed 2016·Granted Mar 9, 2021·0 cites·19 claims
- 0944US2015111816A1Methods and treatment with glp-1 receptor agonistsPHASEBIO PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1040US2013090285A1Methods of treatment with glp-1 receptor agonistsGEORGOPOULOS LYNNE M·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lynne Georgopoulos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →